Evidence map›Paper›PMID 26928983›Full record

Trial reportPediatric blood & cancer2016

Investigating the Experiences of Childhood Cancer Patients and Parents Participating in Optional Nontherapeutic Clinical Research Studies in the UK.

Julie Errington, Ghada Malik, Julie Evans, Jenny Baston, Annie Parry, Lisa Price, Hina Johnstone, Selena Peters, Victoria Oram, Karen Howe and 3 more

Abstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Pediatric blood & cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Julie ErringtonNorthern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
Ghada MalikNorthern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
Julie EvansPediatric Oncology and Haematology, Leeds General Infirmary, Leeds, UK.
Jenny BastonPediatric Oncology and Haematology, Leeds General Infirmary, Leeds, UK.
Annie ParryClinical Trials Unit, Great North Children's Hospital, Newcastle upon Tyne, UK.
Lisa PriceClinical Trials Unit, Great North Children's Hospital, Newcastle upon Tyne, UK.
Hina JohnstoneClinical Trials Unit, Great North Children's Hospital, Newcastle upon Tyne, UK.
Selena PetersInstitute for Child Life and Health, Bristol University, Bristol, UK.
Victoria OramInstitute for Child Life and Health, Bristol University, Bristol, UK.
Karen HoweGreat Ormond Street Hospital, London, UK.
Emma WhiteleyRoyal Manchester Children's Hospital, Manchester, UK.
Jane TunnacliffeAddenbrooke's Hospital, Cambridge, UK.
Gareth J VealNorthern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhile the majority of childhood cancer clinical trials are treatment related, additional optional research investigations may be carried out that do not directly impact on treatment. It is essential that these studies are conducted ethically and that the experiences of families participating in these studies are as positive as possible.

methodsA questionnaire study was carried out to investigate the key factors that influence why families choose to participate in optional nontherapeutic research studies, the level of understanding of the trials involved, and the experiences of participation.

resultsA total of 100 participants from six UK centers were studied; 77 parents, 10 patients >16 years, and 13 patients aged 8-15 years. Ninety-seven percent of parents and 90% of patients felt that information provided prior to study consent was of the right length, with 52% of parents and 65% of patients fully understanding the information provided. Seventy-four percent of parents participated in research studies in order to "do something important", while 74% of patients participated "to help medical staff". Encouragingly, <5% of participants felt that their clinical care would be negatively affected if they did not participate. Positive aspects of participation included a perception of increased attention from medical staff. Negative aspects included spending longer periods in hospital and the requirement for additional blood samples. Ninety-six percent of parents and 87% of patients would participate in future studies.

conclusionsThe study provides an insight into the views of childhood cancer patients and their parents participating in nontherapeutic clinical research studies. Overwhelmingly, the findings suggest that participation is seen as a positive experience.

Indexed as

NeoplasmsParentsPatient Education as TopicPatient ParticipationSurveys and QuestionnairesAdolescentAdultChildClinical Trials as TopicFemaleHumansMaleUnited Kingdomclinical trialsparentspatient experiencespediatricsresearch

Identifiers

PMID26928983
PMCPMC5031198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.